As of 2025-12-28, the Intrinsic Value of Cerevel Therapeutics Holdings Inc (CERE) is -12.64 USD. This CERE valuation is based on the model Peter Lynch Fair Value. With the current market price of 44.96 USD, the upside of Cerevel Therapeutics Holdings Inc is -128.11%.
Based on its market price of 44.96 USD and our intrinsic valuation, Cerevel Therapeutics Holdings Inc (CERE) is overvalued by 128.11%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -12.64 - -12.64 | -12.64 | -128.11% |
| P/E | (49.34) - (40.34) | (43.28) | -196.3% |
| DDM - Stable | (23.87) - (98.01) | (60.94) | -235.5% |
| DDM - Multi | (1.37) - (4.39) | (2.09) | -104.6% |
| Market Cap (mil) | 8,191.26 |
| Beta | 1.22 |
| Outstanding shares (mil) | 182.19 |
| Enterprise Value (mil) | 8,208.75 |
| Market risk premium | 4.60% |
| Cost of Equity | 8.87% |
| Cost of Debt | 5.00% |
| WACC | 8.71% |